Related by context. All words. (Click for frequent words.) 76 relapsed MM 76 recurrent glioblastoma multiforme 75 cisplatin gemcitabine 75 gastrointestinal stromal tumor GIST 75 anthracycline taxane 75 metastatic malignant 74 adjuvant GIST 74 refractory NSCLC 74 mRCC 73 dasatinib Sprycel ® 73 unresectable 73 docetaxel Taxotere ® 73 ACTEMRA TM 73 metastatic neuroendocrine tumors 73 adriamycin 72 myelodysplastic myeloproliferative diseases 72 recurrent metastatic 72 stage IIIB 72 stage IIIb IV 72 tumors GIST 72 dacarbazine 72 Cutaneous T 72 metastatic colorectal 72 biliary tract cancer 72 advanced metastatic renal 72 FOLFOX4 72 papillary renal cell carcinoma 72 recurrent NSCLC 72 FluCAM arm 72 infliximab monotherapy 72 MAGE A3 ASCI 71 metastatic gastric 71 Folfox 71 FUSILEV enhances 71 metastatic pancreatic 71 KRAS mutations occur 71 refractory chronic lymphocytic 71 Soft Tissue Sarcoma 71 non splenectomized 71 doxorubicin cyclophosphamide 71 Paraplatin ® 71 4mg/kg 71 PEGINTRON TM 71 splenectomized 71 relapsed refractory multiple myeloma 71 estramustine 71 cyclophosphamide methotrexate 71 ® lenalidomide 71 deep venous thromboses 71 Mg Uk 71 Mg Usa 71 Refractory Hodgkin Lymphoma 71 erlotinib Tarceva ® 71 Pemetrexed 71 Hormone Refractory Prostate Cancer 71 CYT# potent vascular disrupting 71 recurrent malignant glioma 71 dacarbazine DTIC 71 chemotherapy cisplatin 71 Vidaza ® 71 galiximab 71 Known hypersensitivity 71 complement inhibitor eculizumab 70 sorafenib Nexavar 70 carboplatin paclitaxel 70 TO AVOID PREGNANCY WHILE 70 Aflibercept 70 5 FU leucovorin 70 TAXOTERE R 70 plus dexamethasone 70 fallopian tube carcinoma 70 SPRYCEL ® 70 advanced hepatocellular carcinoma 70 unresectable locally advanced 70 hypereosinophilic syndrome 70 myocardial infarction ventricular fibrillation 70 metastatic malignant melanoma 70 metastatic CRC 70 alfa 2a 70 relapsing remitting MS RRMS 70 haematologic 70 FOLFIRI alone 70 evaluating tivozanib 70 novel VDA molecule 70 Flu Cy 70 gastrointestinal stromal tumors GIST 70 non squamous NSCLC 70 cisplatin chemotherapy 70 situ CIS 70 refractory multiple myeloma 70 saline placebo 70 endometrial hyperplasia 70 Infusion Reactions Severe 70 bevacizumab Avastin ® 70 Fludara 70 CIMZIA TM certolizumab pegol 70 PREZISTA r 70 8mg/kg 70 fallopian tube cancers 70 R lenalidomide 70 Hepatocellular Carcinoma HCC 70 Navelbine ® 70 chemoradiation therapy 70 metastatic renal cell carcinoma 70 tumor lysis syndrome 70 cancer mCRC 70 interferon alfa 2b 70 achieved ACR# 70 Kit CD# positive 70 nonmetastatic 70 5 fluorouracil leucovorin 70 Platinol ® cisplatin 70 sorafenib tablets 70 Gliadel Wafer 70 EGFR HER2 70 biologic DMARD 69 invasive candidiasis 69 interferon alfa 2a 69 cetuximab Erbitux R 69 cell carcinoma RCC 69 Oral Fingolimod 69 EGFR expressing mCRC 69 ZACTIMA 69 receiving INTRON 69 forodesine 69 Complicated Skin 69 ara C 69 VELCADE melphalan 69 Doxil ® 69 Peginterferon alfa 2b 69 lenalidomide Revlimid R 69 alefacept 69 flutamide 69 postoperative chemotherapy 69 thalidomide Thalomid 69 BCG refractory carcinoma 69 leukemia AML 69 gemcitabine carboplatin 69 Myelofibrosis 69 interferon gamma 1b 69 kidney urologic 69 R Saizen R 69 partial remissions 69 Tarceva TM 69 unresectable HCC 69 refractory cutaneous T 69 comparator arm 69 cell lymphoma CTCL 69 TNF Tumor Necrosis Factor 69 Temodar ® 69 HBeAg negative 69 unresectable stage 69 intravesical infusion therapy 69 hormone refractory metastatic prostate 69 HBeAg negative patients 69 ZOLINZA 69 prostate TURP 69 Mitomycin C 69 resectable pancreatic cancer 69 ß blockers 69 Myelodysplastic Syndrome MDS 69 neutropenia dehydration dyspnea 69 investigational immunotherapy 69 chlorambucil 69 Follicular Lymphoma 69 YONDELIS 69 essential thrombocythemia ET 69 advanced unresectable 69 overt nephropathy 69 Adjuvant chemotherapy 69 INTEGRILIN R 69 leukemia APL 69 naïve HCV 69 symptomatic BPH 69 Velcade bortezomib 69 sarcomatoid 69 Peginterferon Alfa 2a 69 Zorbtive TM 69 placebo dexamethasone 69 pegylated liposomal doxorubicin 69 assessing T DM1 69 hematopoietic cancers 69 mycophenolate mofetil 69 Amgen Neulasta R 69 recurrent glioblastoma 69 Advanced Renal Cell 69 IMiDs ® compound 69 atypical Hemolytic Uremic Syndrome 68 Gemzar ® 68 Xeloda ® 68 herpetic keratitis 68 receiving VELCADE 68 Kepivance 68 hyperplasia BPH 68 PDX pralatrexate 68 histologic subtype 68 Papillary 68 clodronate 68 Castration Resistant Prostate Cancer 68 Leukemias 68 metastatic castration resistant 68 Wafer polifeprosan 68 fluoropyrimidine 68 anthracycline containing 68 systemic anaplastic large 68 chronic ITP patients 68 evaluating picoplatin 68 NMIBC 68 autoantibody positive 68 mCRC patients 68 octreotide LAR 68 hepatic metastases 68 pancreatic carcinoma 68 elevated transaminases 68 relapsed multiple myeloma 68 unresectable tumors 68 carcinoma mCRC 68 hepatorenal syndrome 68 mcg kg REBETOL 68 metastatic HRPC 68 severe neutropenia 68 folinic acid 68 erosive gastritis 68 peginterferon alfa 2a Pegasys 68 Newly Diagnosed Multiple Myeloma 68 adult chronic ITP 68 relapsed CLL 68 LHRH receptor positive 68 chronic eosinophilic leukemia 68 alkylating agent 68 See WARNINGS 68 mg m² 68 severe renal impairment 68 DOXIL 68 catheter occlusion 68 lopinavir r arm 68 pancreatic adenocarcinoma 68 Lupus Nephritis 68 Fludara ® 68 FOLFOX6 68 anthracyclines taxanes 68 arthritis PsA 68 refractory gout 68 invasive aspergillosis 68 Relapsed Refractory 68 hypertrichosis occurred 68 monoclonal antibody conjugated 68 Peginterferon 68 alpha interferons 68 ergot derivatives 68 adalimumab Humira 68 receiving PEGINTRON 68 Meets Primary Endpoint 68 Combination REOLYSIN R 68 Elotuzumab 68 ribavirin RBV 68 CIMZIA ™ 68 thrombocytopenic 68 Neoadjuvant 68 Adjuvant Treatment 68 gefitinib Iressa 68 certolizumab 68 metastatic RCC 68 amoxicillin clavulanate 68 FASLODEX 68 vinorelbine 68 ELOXATIN 68 systemic ALCL 68 postmenopausal osteoporotic women 68 oral clodronate 68 Amrubicin 68 neoadjuvant therapy 68 resistant hormone refractory 68 Genasense ® 68 Sezary syndrome 68 voriconazole 68 induced macular edema 68 Pivotal Phase III 68 abacavir lamivudine 68 oropharyngeal candidiasis OPC 68 interferon beta 1a infertility 68 Naive Patients 68 receiving highly emetogenic 68 prostate cancer HRPC 68 Relapsed Refractory Multiple Myeloma 68 acute GvHD 68 Ribavirin causes 68 colorectal liver metastases 68 Phase #b/#a clinical 68 receptor tyrosine kinase inhibitor 68 vincristine doxorubicin 68 HCV RESPOND 2 68 refractory metastatic colorectal cancer 68 pan histone deacetylase 68 keloid scarring 68 tamoxifen Nolvadex ® 68 candidemia 68 BARACLUDE ® 68 ALN HPN 68 AVASTIN 68 esophageal candidiasis 68 receiving prophylactic anticoagulation 68 histological subtype 68 Brentuximab Vedotin SGN 68 paclitaxel Taxol ® 68 GLIADEL R Wafer 68 locoregional 68 cetuximab Erbitux ® 68 ribavirin therapy 68 Advanced Melanoma 68 Pegylated Interferon 68 resectable 68 plus prednisone 68 sunitinib Sutent ® 68 colesevelam HCl 68 Cloretazine 68 pegylated interferon alpha 67 PEGylated Fab fragment 67 leukemia CLL 67 5-FU/LV 67 platinum refractory 67 familial amyloidotic polyneuropathy FAP 67 del 5q MDS 67 Squamous 67 hyperphenylalaninemia HPA due 67 demonstrated antitumor activity 67 Randomized Phase II 67 mild renal insufficiency 67 EGFR mutation positive 67 multiple myeloma MM 67 Dementia Related Psychosis 67 Ovitrelle R Serostim 67 Investigational Treatment 67 treatment naive genotype 67 non squamous 67 Metastatic Colorectal Cancer 67 FEMALES SHOULD BE ADVISED 67 mapatumumab 67 cutaneous T 67 allogeneic hematopoietic stem cell 67 malignant pleural mesothelioma 67 primary hypercholesterolemia 67 docetaxel chemotherapy 67 locoregional recurrence 67 Diffuse Large B 67 metastatic renal cell 67 pancreatic NET 67 unresectable recurrent 67 biochemical relapse 67 Malignant Glioma 67 mitoxantrone plus 67 Irinotecan 67 CLL SLL 67 vinca alkaloid 67 CTAP# 67 Chronic HCV 67 PEGINTRON REBETOL combination 67 trastuzumab Herceptin ® 67 severe exacerbations 67 subependymal giant cell 67 refractory Hodgkin lymphoma 67 dalteparin 67 achieved CCyR 67 ertapenem 67 INSPIRE Trial Phase III 67 oral rivaroxaban 67 tumor xenograft models 67 Alkeran 67 pain palliation 67 TORISEL 67 FIRMAGON 67 imatinib resistant 67 R sorafenib tablets 67 Patients Receiving 67 ritonavir boosted 67 recurrent metastatic ovarian cancer 67 5 Fluorouracil 67 aflibercept VEGF Trap 67 sunitinib Sutent 67 brand ciclesonide HFA 67 AA Amyloidosis 67 LymphoStat B belimumab 67 Sevelamer 67 HBeAg positive patients 67 dexamethasone Decadron 67 refractory metastatic 67 hepatocellular cancer 67 Prolongs Survival 67 paclitaxel cisplatin 67 generalized edema 67 Vandetanib 67 Hycamtin ® 67 plus gemcitabine 67 de novo kidney transplant 67 underwent surgical resection 67 overactive bladder syndrome 67 basal cell carcinoma BCC 67 benign prostatic hypertrophy BPH 67 included exfoliative dermatitis 67 irinotecan containing 67 Camptosar ® 67 irinotecan doxorubicin oxaliplatin paclitaxel 67 TRISENOX ® 67 chronic idiopathic thrombocytopenic purpura 67 Glioblastoma Multiforme 67 COPEGUS R 67 plus prednisone prednisolone 67 hypervascular tumors 67 bevacizumab Avastin R 67 titrated glipizide 67 minimally symptomatic metastatic castrate 67 ACE Inhibitors 67 CTAP# Capsules 67 metastatic colorectal carcinoma 67 trastuzumab Herceptin R 67 FOLFIRI 67 Bayer HealthCare Onyx Pharmaceuticals 67 heavily pretreated 67 Phase 2b Clinical Trial 67 temsirolimus Torisel ® 67 candesartan cilexetil 67 Vidaza azacitidine 67 lymphoid malignancies 67 pegylated interferon alfa 2a 67 Severe Sepsis 67 rheumatoid arthritis psoriatic arthritis 67 mcg QD 67 oral ridaforolimus 67 adjunctive placebo 67 J Am Coll 67 stage IIIB IV 67 pancreatic neuroendocrine tumors 67 Idiopathic Pulmonary Fibrosis 67 romiplostim 67 RECIST Response Evaluation Criteria 67 rFVIIa 67 prednisone prednisolone plus 67 hemorrhagic cystitis 67 pheochromocytoma 67 oral antidiabetic medication 67 oral Hycamtin 67 vWD 67 monoclonal antibody IgG1 Mab 67 neoadjuvant 67 irinotecan chemotherapy 67 severe hypersensitivity reactions 67 BENICAR HCT 67 pancreatic prostate 67 PREZISTA r arm 67 ULORIC 67 daily Infergen 67 BEXXAR Therapeutic Regimen 67 primary immunodeficiency PI 67 MYLOTARG 67 basiliximab 67 CHOP chemotherapy 67 efalizumab 67 colorectal carcinoma 67 minimally symptomatic 67 epithelial tumors 67 underwent resection 67 antibody MAb 67 PEGylated anti 67 stable angina pectoris 67 Golimumab 67 sorafenib Nexavar ® 67 Perifosine KRX 67 gastroesophageal junction 67 HER2 positive metastatic breast 67 malignancy HCM 67 metastatic androgen independent 67 peginterferon alfa 67 ovarian carcinoma 67 TTF Therapy 67 acetonide FA 67 Darinaparsin 67 BRIM2 67 Patients Treated With 67 #mg #mg #mg [003] 67 castrate resistant prostate cancer 67 pan HDAC inhibitor 67 severe oral mucositis 67 HES CEL 67 tiuxetan 67 FOLFOX4 alone 67 humanized interleukin 6 67 carcinoma HCC 67 BUPHENYL 67 BR.# 66 Lymphocytic 66 MCyR 66 Posaconazole 66 moderate renal impairment 66 Relapsing Multiple Sclerosis 66 goserelin 66 oxycodone CR 66 gemcitabine cisplatin 66 Pegasys ® 66 PROCTOCORT R 66 CINTREDEKIN BESUDOTOX 66 Acetate Rectal Suppositories 66 ceftazidime 66 Primary Hypercholesterolemia 66 plus dacarbazine 66 lexidronam injection 66 squamous histology 66 lumiliximab 66 acute myeloid 66 superficial basal cell carcinomas 66 fluorouracil leucovorin 66 recurrent glioma 66 malignant neoplasms 66 cilengitide 66 ATACAND 66 prostate carcinoma 66 uremic pruritus 66 Nebulized 66 EGFR TKI 66 unfractionated heparin UFH 66 ThermoDox R 66 VEGFR2 inhibitor 66 nilotinib Tasigna ® 66 nicardipine 66 stage IIIA 66 Peg IFN 66 iobenguane 66 allogeneic bone marrow 66 Capecitabine 66 fluorouracil 66 hepatocellular carcinoma HCC 66 idarubicin 66 smoldering multiple myeloma 66 oral allopurinol 66 Chronic Lymphocytic Leukemia 66 oxaliplatin Eloxatin 66 terlipressin 66 chronic thromboembolic pulmonary 66 refractory CTCL 66 myelofibrosis polycythemia vera 66 EXJADE 66 IL# PE#QQR 66 tenofovir emtricitabine 66 receiving XGEVA 66 ARCALYST ® 66 paclitaxel poliglumex 66 AMEVIVE 66 TYKERB 66 Proellex TM 66 IV NSCLC 66 Taxotere ® 66 Noxafil 66 Metastatic Melanoma 66 Navelbine 66 recurrent GBM 66 pegylated interferon alfa 66 insulin glulisine 66 metastatic bladder 66 FOLFOX 66 TELCYTA 66 intravenous RSD# 66 metastatic carcinoma 66 evaluating T DM1 66 piperacillin tazobactam 66 hypercalcemia 66 Chronic lymphocytic leukemia 66 tuberous sclerosis TS 66 Antitumor Activity 66 gastric adenocarcinoma 66 headache nasopharyngitis 66 liposomal doxorubicin 66 alfuzosin 66 Entereg R 66 mycophenolic acid 66 TNF antagonist 66 GW# [003] 66 refractory CLL 66 weekly subcutaneous injections 66 Sudhir Agrawal D.Phil 66 Surgical resection 66 dasatinib Sprycel 66 dependent kinase inhibitor 66 Xyfid TM 66 systemic corticosteroid 66 EFAPROXYN 66 Acute Exacerbations 66 Raptiva r 66 rheumatoid arthritis RA psoriatic 66 Platinol ® 66 Renal Impairment 66 MGd 66 pyrexia mucositis sepsis febrile 66 occlusion PAO 66 registrational Phase 66 Raptiva ® 66 ANCA associated 66 metastatic carcinoid 66 Trial Evaluating 66 non valvular atrial 66 cytoreduction 66 CIMZIA TM 66 refractory AML 66 STRIDE PD 66 Helicobacter pylori eradication 66 GLIADEL Wafer 66 superficial basal cell carcinoma 66 imipenem 66 Decitabine 66 gastrointestinal stromal tumor 66 SinuNase TM 66 r hGH 66 antimetabolite 66 prostate cancer CRPC 66 constipation OIC 66 retinal vein occlusion induced 66 neoadjuvant treatment 66 lintuzumab SGN 66 Bezielle 66 Neulasta R 66 Cytoxan 66 CALGB # [002] 66 Randomized Phase 66 Plaque Psoriasis 66 oral vancomycin 66 doxorubicin HCl liposome injection 66 ORENCIA ® 66 clinically evaluable 66 Azacitidine 66 treatment naïve genotype 66 gemcitabine chemotherapy 66 Jevtana 66 IFN alfa 66 acyclovir Lauriad R 66 Emtriva Viread 66 KRAS wild 66 carcinoid tumors 66 HeFH 66 modified glutathione analog 66 neuroendocrine cancers 66 Pegylated interferon 66 pharmacologically active isomer 66 Erythropoietic therapies may 66 paclitaxel Taxol R 66 colorectal adenoma 66 temsirolimus Torisel 66 pegylated interferon alfa 2b 66 See CLINICAL PHARMACOLOGY 66 skeletal metastases 66 epithelial ovarian 66 delivers fluocinolone acetonide FA 66 Heterozygous Familial Hypercholesterolemia 66 Basal Cell 66 Acute Myelogenous Leukemia AML 66 histologically confirmed 66 transaminase elevation 66 antithymocyte globulin 66 alemtuzumab treated 66 posaconazole 66 hypophosphatemia 66 doxorubicin Adriamycin 66 erythematosus 66 ipsilateral breast 66 eosinophilic asthma 66 VFEND 66 cIAI 66 SUPPRELIN R LA 66 thromboembolic events 66 telaprevir dosed 66 Abrupt discontinuation 66 INCB# [003] 66 lipid lowering agents 66 Plus Ribavirin 66 anthracycline chemotherapy 66 follicular lymphoma FL 66 hydroxymethyl coenzyme 66 melphalan prednisone 66 Vicinium TM 66 chronic GVHD 66 efaproxiral 66 receiving chemoradiation therapy 66 Hurthle cell 66 calcineurin inhibitor 66 Valcyte tablets 66 letrozole Femara 66 #.#mg/dL 66 MYCAMINE 66 TMP SMX 66 imatinib Gleevec 66 cytogenetic response 66 deletion 5q 66 hematologic toxicity 66 SCIg 66 IMiDs ® 66 opioid induced constipation OIC 66 PRN FDA Approves 66 mertansine 66 palifermin 65 KRAS mutant tumors 65 reduce serum phosphate 65 temsirolimus 65 trimethoprim sulfamethoxazole 65 docetaxel Taxotere R 65 Xeloda capecitabine 65 low dose cytarabine 65 irbesartan 65 R metformin Concor 65 CR nPR 65 #mg/m# [001] 65 HGS ETR1 mapatumumab 65 mcg albinterferon alfa 2b 65 NovoTTF 65 Renal impairment 65 K ras mutations 65 daunorubicin 65 HCV SPRINT 65 #mg BID [001] 65 Atypical Hemolytic Uremic Syndrome 65 vinorelbine tartrate 65 relapsed leukemia 65 indolent follicular non 65 vapreotide acetate 65 leiomyomas 65 Intravitreal 65 morphometric vertebral fractures 65 sodium thiosulfate STS 65 AVONEX ® 65 cisplatin resistant 65 Omacetaxine 65 cutaneous squamous cell carcinoma 65 either acutely decompensated 65 COPEGUS therapy 65 completely resected 65 CYP#A# CYP#D# 65 REVLIMID R 65 Taxotere R 65 reteplase 65 Ophena TM 65 headache abdominal pain 65 NeuroStar TMS Therapy 65 imatinib mesylate 65 unstable angina UA 65 adjuvant radiation 65 Metastatic Prostate Cancer 65 Orally administered 65 cisplatin vinorelbine 65 abacavir Ziagen 65 chronic immune thrombocytopenic 65 somatostatin analog 65 refractory acute myeloid 65 BCG refractory 65 mcg BID 65 moderate hepatic impairment 65 q8h 65 PEG interferon 65 EURIDIS 65 Xelox 65 grade cervical intraepithelial 65 dihydrochloride 65 known sulfonamide allergy 65 potent CYP#A# inhibitors 65 nucleoside naive 65 stage IIIb 65 CCyR 65 squamous 65 NATRECOR R 65 acute promyelocytic leukemia APL 65 Epirubicin 65 dacarbazine chemotherapy 65 PREZISTA ritonavir 65 cyclophosphamide chemotherapy 65 interferon ribavirin 65 essential thrombocythemia 65 distant metastasis 65 lymphocytosis 65 salmeterol fluticasone propionate 65 microbiologically evaluable 65 variceal hemorrhage 65 Mitoxantrone 65 Achieves Primary Endpoint 65 Host Disease 65 metabolic alkalosis 65 Tumor Response 65 lymphoma CTCL 65 bone marrow reticulin deposition 65 CK # administered 65 Initiate Phase 65 adefovir treated 65 Natalizumab 65 Luveris R Ovidrel R 65 Telithromycin 65 NOLVADEX 65 bladder ovarian 65 CAELYX 65 adefovir dipivoxil 65 BENLYSTA ® 65 evaluating Xcytrin 65 nonmetastatic prostate cancer 65 metastatic hormone refractory 65 methylnaltrexone bromide 65 PROCTOCORT ® Suppository Hydrocortisone 65 cystic fibrosis chronic pancreatitis 65 anastrazole 65 LEUKINE 65 diarrhea predominant irritable 65 BUPHENYL R sodium phenylbutyrate 65 metastatic kidney 65 CMV disease 65 polycythemia vera PV 65 Bevacizumab 65 metachronous 65 R adefovir dipivoxil 65 lymphomas leukemias 65 VIIBRYD 65 Randomized Double blind 65 TELINTRA 65 capecitabine Xeloda 65 peritoneal cancer 65 complete cytogenetic response 65 thyrotoxicosis 65 FOLOTYN ® 65 anagrelide 65 metastatic renal 65 tolterodine ER 65 metastatic HER2 negative 65 Allovectin 7 ® 65 humanised monoclonal antibody 65 seminoma 65 corticosteroid therapy 65 protease inhibitor PI 65 Squamous Cell Carcinoma 65 B Cell Lymphoma 65 gastrointestinal stromal 65 steroid refractory GvHD 65 parathyroid carcinoma 65 indinavir Crixivan 65 vandetanib 65 mg administered orally 65 imatinib Gleevec ® 65 Fludarabine 65 Tamibarotene 65 GnRH agonist 65 including cyclosporine methotrexate 65 cutaneous melanoma 65 active thrombophlebitis 65 polycythemia vera essential thrombocythemia 65 subcutaneous immunoglobulin 65 FOLFOX6 chemotherapy regimen 65 R rilonacept Injection 65 post herpetic neuralgia PHN 65 sodium stibogluconate 65 gadobutrol 65 heparin induced thrombocytopenia 65 interferon alfa 65 refractory myeloma 65 bortezomib Velcade R 65 rFSH 65 prucalopride 65 allogeneic stem cell 65 Chronic Myeloid Leukemia 65 colorectal adenocarcinoma 65 plus COPEGUS 65 unstable angina pectoris 65 toenail onychomycosis 65 oral picoplatin 65 HIV HCV coinfected 65 preoperative chemotherapy 65 Toxicities 65 carbamazepine phenobarbital phenytoin rifampin 65 orally administered inhibitor 65 MOVIPREP R 65 Renal Cell Carcinoma 65 infusional 65 metastatic carcinoid tumors 65 Vincristine 65 TAXOTERE ® 65 Degarelix 65 cyclophosphamide Cytoxan 65 chemoembolization 65 alvespimycin 65 chronic myeloid 65 COMBIVIR 65 chronic hemodialysis 65 mycosis fungoides 65 Nilotinib 65 adjunctive ABILIFY 65 azacitidine 65 renal cell carcinomas 65 radiochemotherapy 65 CD3 monoclonal antibody 65 corticosteroid dose 65 localized prostate 65 Chronic Hepatitis C 65 Non Alcoholic Steatohepatitis 65 aplastic anemia AA 65 mg q#h 65 Vidaza R 65 ovarian breast 65 Pyridorin 65 relapsing multiple sclerosis 65 FOLPI 65 PAOD 65 metastatic castrate resistant 65 Dupuytren Disease 65 Engerix B 65 nadolol 65 papillary carcinoma 65 gastrointestinal stromal tumors 65 radioiodine therapy 65 HERCEPTIN 65 exocrine pancreatic insufficiency EPI 65 Serostim ® 65 differentiated thyroid 65 mg qd 65 pT3 65 phase III isavuconazole 65 AEGR 65 REYATAZ r arm 65 ALT flares 65 treat benign prostatic 65 Fluorouracil 65 vitamin B# folic acid 65 Nexavar prescribing 65 Fibrillex TM 65 percutaneous transluminal coronary angioplasty 65 chemoradiotherapy 65 Clolar ® 65 recurrent DVT 65 non resectable 65 Pegylated Liposomal Doxorubicin 65 Invasive Breast Cancer 65 AAG geldanamycin analog 65 Soriatane R 65 smoldering myeloma 65 INFERGEN 65 HBeAg + 65 plus OBT 65 Response Evaluation Criteria 65 diarrhea vomiting nausea 65 ibandronate 65 eribulin mesylate 65 TLK# 65 concurrent chemoradiation 65 standard chemotherapy regimen 65 docetaxel Taxotere 65 secondary hyperparathyroidism 65 Navelbine R 65 lichen planus 65 5 FU capecitabine 65 oblimersen 65 CANCIDAS 65 Albuferon TM 65 cabazitaxel 65 mg ustekinumab 65 Proxinium TM 65 icatibant 65 sitaxsentan 65 Lenalidomide 65 pamidronate 65 Zevalin R Ibritumomab 65 pegylated interferon peg IFN 65 Myelodysplastic Syndrome 65 hormone LHRH antagonist 65 peritoneal carcinomatosis 65 cromolyn sodium 65 emtricitabine tenofovir 65 ALVESCO ® 65 benazepril 65 cytopenias 65 x ULN 65 T1c 65 cediranib 65 peginterferon alfa 2b 65 Pooled Analysis 65 FS Antihemophilic Factor Recombinant 65 Renal Cell Carcinoma RCC 65 Xanafide 65 Actimmune ® 65 nab paclitaxel 65 NEUPOGEN 65 develop HBV reactivation 65 diarrhea fatigue asthenia 65 acarbose 65 antiangiogenic therapy 65 colorectal pancreatic 65 unresectable liver cancer 65 acute peripheral arterial 65 Coadministration 65 CIMZIA R 65 Ceplene/IL-2 65 Hodgkin lymphoma HL 65 Enzastaurin 65 paclitaxel carboplatin 65 hepatic failure 65 bone marrow suppression 65 peritumoral brain edema 65 PROSTVAC VF 65 malignant neoplasm 65 2 methoxyestradiol 65 antiarrhythmic drug 65 malignant ovarian